Trial Profile
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Tamoxifen
- Indications Breast cancer
- Focus Pharmacodynamics
- Acronyms Co-STAR
- 21 Sep 2009 Endpoints 'California Verbal Learning Test,' 'Cognitive Function Tests,' 'Geriatric Depression Scale' and 'Mini Mental State Examination' have not been met according to Jornal of Clinical Oncology article.
- 21 Sep 2009 Results published in Journal of Clinical Oncology article.
- 29 Jul 2008 Results presented at the ICAD 2008. Actual patient number was 1498.